The US Food and Drug Administration has approved TNKase (tenecteplase), a thrombolytic or clot-dissolving agent, for the treatment of acute ischemic stroke in adults.

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Protagonist Therapeutics (PTGX – Research Report) and Roche ...

Individuals with high PLMs had significantly higher Fazekas and ARWMC total scores than those with a lower PLM index.

Additionally, please note the following Stroke specific guidelines. Optional: Stroke posts about its published articles on Facebook and Twitter. If you would like us to include an author or department ...